Clinical scenario: Thalassemia major | T2 MRI fallen
A 7-year-old boy with transfusion-dependent β-thalassemia major has been receiving packed red cell transfusions every 3–4 weeks since infancy. He is compliant with iron chelation therapy. During routine follow-up, his serum ferritin is 1,200 µg/L, liver iron concentration is acceptable, but cardiac T2* MRI has fallen from 22 ms to 8 ms over the past year. Echocardiography shows a mildly reduced left ventricular ejection fraction (50%), although he remains asymptomatic.
What is the most appropriate next step in management?
A. Continue the same oral iron chelator and repeat MRI after 12 months
B. Increase the pre-transfusion hemoglobin target to 12.5 g/dL
C. Intensify iron chelation with combination therapy aimed at rapid myocardial iron removal
D. Reduce transfusion frequency to minimize further iron accumulation
E. Proceed to splenectomy because of progressive cardiac siderosis
correct answer & Explanation:
Correct Answer: C. Intensify iron chelation with combination therapy aimed at rapid myocardial iron removal
Explanation
This child has significant myocardial iron overload, demonstrated by a cardiac T2 MRI of 8 ms.
- Cardiac T2 is the gold standard for assessing myocardial iron deposition.
- Interpretation:
- >20 ms: Normal or minimal cardiac iron
- 10–20 ms: Mild to moderate myocardial iron loading
- <10 ms: Severe myocardial iron overload with a high risk of heart failure and arrhythmias
Although the serum ferritin is only moderately elevated (1,200 µg/L), serum ferritin correlates poorly with myocardial iron. Cardiac iron can worsen despite apparently acceptable ferritin levels and liver iron concentration.
The presence of:
- Cardiac T2* = 8 ms
- Declining LV systolic function (EF 50%)
requires urgent intensification of iron chelation, typically:
- Combination therapy (e.g., deferiprone + deferoxamine), or
- An appropriately intensified regimen according to current thalassemia guidelines.
Early aggressive chelation can reverse myocardial siderosis and improve ventricular function.
Why the other options are incorrect
A. Continue the same oral iron chelator
- Incorrect. Severe cardiac siderosis requires escalation of therapy. Waiting another year risks irreversible cardiomyopathy.
B. Increase the pre-transfusion hemoglobin target
- Maintaining pre-transfusion Hb around 9–10.5 g/dL suppresses ineffective erythropoiesis, but increasing the target does not treat cardiac iron overload.
D. Reduce transfusion frequency
- Incorrect. This would worsen anemia, increase ineffective erythropoiesis, and promote marrow expansion. Iron overload should be managed with chelation, not by withholding necessary transfusions.
E. Splenectomy
- Splenectomy is reserved for hypersplenism or markedly increased transfusion requirements. It has no role in treating myocardial iron overload.
High-yield pearl (MRCPCH/FCPS)
- The best predictor of cardiac complications in thalassemia major is cardiac T2 MRI, not serum ferritin.
- T2 <10 ms is a medical emergency requiring aggressive/intensified iron chelation, even if the patient has minimal symptoms and ferritin is not markedly elevated.
